4.3 Editorial Material

Optogenetic stimulation: Understanding memory and treating deficits

期刊

HIPPOCAMPUS
卷 28, 期 7, 页码 457-470

出版社

WILEY
DOI: 10.1002/hipo.22960

关键词

Alzheimer's disease; amnesia; anterior thalamic nucleus; mediodorsal thalamus; nucleus reuniens

资金

  1. Brain Research New Zealand

向作者/读者索取更多资源

Technology allowing genetically targeted cells to be modulated by light has revolutionized neuroscience in the past decade, and given rise to the field of optogenetic stimulation. For this, non-native, light activated proteins (e.g., channelrhodopsin) are expressed in a specific cell phenotype (e.g., glutamatergic neurons) in a subset of central nervous system nuclei, and short pulses of light of a narrow wavelength (e.g., blue, 473 nm) are used to modulate cell activity. Cell activity can be increased or decreased depending on which light activated protein is used. We review how the greater precision provided by optogenetics has transformed the study of neural circuits, in terms of cognition and behavior, with a focus on learning and memory. We also explain how optogenetic modulation is facilitating a better understanding of the mechanistic underpinnings of some neurological and psychiatric conditions. Based on this research, we suggest that optogenetics may provide tools to improve memory in neurological conditions, particularly diencephalic amnesia and Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Mediodorsal Thalamus Is Critical for Updating during Extradimensional Shifts But Not Reversals in the Attentional Set-Shifting Task

Zakaria Ouhaz, Brook A. L. Perry, Kouichi Nakamura, Anna S. Mitchell

Summary: Cognitive flexibility is crucial for navigating everyday complexities and is attributed to the frontal cortex. The mediodorsal thalamus (MD), connected to the frontal cortex, may play a role in influencing cognitive flexibility. This study using male rats found that MD lesions resulted in difficulties in learning and updating strategies during a set-shifting task.

ENEURO (2022)

Review Cell Biology

Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson?s disease

Elodie Kip, Louise C. Parr-Brownlie

Summary: This article discusses the role of neuroinflammation in the onset and progression of Parkinson's disease (PD) and emphasizes the importance of reducing neuroinflammation early on to prevent PD. The article also mentions some risk and protective factors and discusses treatments for neuroinflammation associated with PD.

AGEING RESEARCH REVIEWS (2022)

Article Clinical Neurology

Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia

Judith A. Boel, Rob M. A. Bie, Ben A. Schmand, John C. Dalrymple-Alford, Connie Marras, Charles H. Adler, Jennifer G. Goldman, Alexander Troster, David J. Burn, Irene Litvan, Gert J. Geurtsen

Summary: The predictive value of global cognitive tests for conversion from PD-MCI to PDD is lower compared to comprehensive neuropsychological assessment. Level II neuropsychological assessment is the preferred method for evaluating PD-MCI.

MOVEMENT DISORDERS CLINICAL PRACTICE (2022)

Article Clinical Neurology

Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease

Joseph Blommer, Toni Pitcher, Maja Mustapic, Erden Eren, Pamela J. Yao, Michael P. Vreones, Krishna A. Pucha, John Dalrymple-Alford, Reza Shoorangiz, Wassilios G. Meissner, Tim Anderson, Dimitrios Kapogiannis

Summary: The protein cargo of neuronal extracellular vesicles may serve as a biomarker for cognitive impairment in Parkinson's disease, with differences in alpha-synuclein, phosphorylated tau, and proteins associated with insulin signaling observed between patients with and without cognitive impairment. These findings could provide insights into the underlying pathogenic processes and improve diagnosis and prognosis of Parkinson's disease. Plasma samples from 273 participants were used in the study, and immunoassays were utilized to quantify biomarkers in plasma extracellular vesicles enriched for neuronal origin. Alpha-synuclein, phosphorylated tau, and insulin receptor substrate-1 phosphorylated tyrosine showed diagnostic classification contributions between groups, indicating that both alpha-synuclein and tau pathologies, along with impaired insulin signaling, may underlie Parkinson's disease with cognitive impairment. Plasma neuronal extracellular vesicles biomarkers may inform cognitive prognosis in Parkinson's disease.
Article Neurosciences

Oscillatory waveform sharpness asymmetry changes in motor thalamus and motor cortex in a rat model of Parkinson's disease

Louise C. Parr-Brownlie, Christy A. Itoga, Judith R. Walters, Conor F. Underwood

Summary: Parkinson's disease and dopamine loss have significant effects on the activity of motor thalamus and motor cortex. Dopamine lesion decreases the firing rate of layer V pyramidal neurons in the motor cortex, while not affecting the activity of ventroanterior-ventrolateral thalamus. Parkinson's disease is also associated with an increase in oscillatory waveform sharpness asymmetry in both motor thalamus and motor cortex.

EXPERIMENTAL NEUROLOGY (2022)

Review Neurosciences

Cortico-thalamocortical interactions for learning, memory and decision-making

Brook A. L. Perry, Juan Carlos Mendez, Anna S. Mitchell

Summary: The thalamus and cortex are interconnected both functionally and anatomically and share a common developmental trajectory. Interactions between the mediodorsal thalamus (MD) and different parts of the prefrontal cortex are essential in cognitive processes. Cortico-thalamocortical interactions involving other dorsal thalamic nuclei also influence these cognitive processes.

JOURNAL OF PHYSIOLOGY-LONDON (2023)

Article Multidisciplinary Sciences

The New Zealand Parkinson's progression programme

Michael R. MacAskill, Toni L. Pitcher, Tracy R. Melzer, Daniel J. Myall, Kyla-Louise Horne, Reza Shoorangiz, Mustafa M. Almuqbel, Leslie Livingston, Sophie Grenfell, Maddie J. Pascoe, Ethan T. Marshall, Steven Marsh, Sarah E. Perry, Wassilios G. Meissner, Catherine Theys, Campbell J. Le Heron, Ross J. Keenan, John C. Dalrymple-Alford, Tim J. Anderson

Summary: The New Zealand Parkinson's Progression Programme (NZP3) focuses on studying cognitive impairment in Parkinson's disease patients, identifying biomarkers and standard criteria for mild cognitive impairment (MCI). The programme utilizes brain imaging techniques such as MRI and PET to show associations between brain pathology and declining cognitive function. It also explores other biomarkers including genetics, fluid biomarkers, eye movement, speech, and EEG.

JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND (2023)

Article Physiology

Investigating Fractal Analysis as a Diagnostic Tool That Probes the Connectivity of Hippocampal Neurons

Conor Rowland, Bruce Harland, Julian H. Smith, Saba Moslehi, John Dalrymple-Alford, Richard P. Taylor

Summary: The study explores the relationship between fractal scaling of neuronal dendrites and connectivity, considering the impact of pathological states on this optimization process. Rats exposed to enriched housing and spatial memory training exhibited higher complexity and connectivity in dendritic arbors. The findings suggest that morphological differences induced by lesions are not significant enough to affect the optimization process in achieving an optimal balance between connectivity and material cost.

FRONTIERS IN PHYSIOLOGY (2022)

Article Neurosciences

Anterior thalamic nuclei: A critical substrate for non-spatial paired-associate memory in rats

Jennifer J. Hamilton, John C. Dalrymple-Alford

Summary: Injury or dysfunction in the anterior thalamic nuclei (ATN) plays a crucial role in diencephalic amnesia. Experimental studies have shown that ATN lesions impair spatial memory and temporal discriminations, but the role in non-spatial memory is limited. This study demonstrates that ATN lesions completely block the acquisition of biconditional associations between odour and object pairings, suggesting that diencephalic amnesia associated with ATN stems from degraded attention to stimulus-stimulus associations.

EUROPEAN JOURNAL OF NEUROSCIENCE (2022)

Article Multidisciplinary Sciences

Dementia Prevention Research Clinic: a longitudinal study investigating factors influencing the development of Alzheimer's disease in Aotearoa, New Zealand

Lynette J. Tippett, Erin E. Cawston, Catherine A. Morgan, Tracy R. Melzer, Kiri L. Brickell, Christina Ilse, Gary Cheung, Ian J. Kirk, Reece P. Roberts, Jane Govender, Leon Griner, Campbell Le Heron, Sarah Buchanan, Waiora Port, Makarena Dudley, Tim J. Anderson, Joanna M. Williams, Nicholas J. Cutfield, John C. Dalrymple-Alford, Phil Wood

Summary: This study aims to explore and improve understanding of Alzheimer's Disease and dementia, in order to delay or prevent the progression of dementia. Through multidisciplinary collaboration, regular examinations are conducted on community participants to collect and analyze various biomarkers and risk factors, and to study the mechanisms underlying disease progression. The national outreach of the Dementia Prevention Research Clinics is one of its strengths.

JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND (2023)

Article Neurosciences

Dynamic interaction between hippocampus, orbitofrontal cortex, and subthalamic nucleus during goal conflict in the stop signal task in rats

Ashik Banstola, Calvin K. Young, Louise Parr-Brownlie, Neil McNaughton

Summary: The cessation of action relies on at least two frontal circuits and a third limbic circuit that operates in the frequency typical of hippocampal theta. The study investigates in male rats whether stop-go conflict involves the hippocampus and whether theta-modulated information is transmitted to the subthalamic nucleus through the frontal cortex. The results suggest the presence of a third limbic circuit that contributes to stopping action when go responses are slow.

NEUROSCIENCE RESEARCH (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Reproducibility and repeatability of magnetic resonance imaging in dementia

Catherine A. Morgan, Reece P. Roberts, Tessa Chaffey, Lenore Tahara-Eckl, Meghan van der Meer, Matthias Gunther, Timothy J. Anderson, Nicholas J. Cutfield, John C. Dalrymple-Alford, Ian J. Kirk, Donna Rose Addis, Lynette J. Tippett, Tracy R. Melzer

Summary: This study assessed the repeatability and reproducibility of MRI markers derived from a dementia protocol, finding that structural markers were less variable than functional MRI markers.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2022)

Review Biochemistry & Molecular Biology

Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions

Jian Guan, Fengxia Li, Dali Kang, Tim Anderson, Toni Pitcher, John Dalrymple-Alford, Paul Shorten, Gagandeep Singh-Mallah

Summary: The decline of insulin-like growth factor-1 (IGF-1) function with age is associated with brain aging and age-related neurological conditions. Cyclic glycine-proline (cGP) and IGF binding protein-3 (IGFBP-3) collectively regulate the bioavailability of IGF-1. The ratio of cGP/IGF-1 is associated with clinical outcomes, memory retention, and age-related brain diseases.

MOLECULES (2023)

Article Neurosciences

Patterned Stimulation of the Chrimson Opsin in Glutamatergic Motor Thalamus Neurons Improves Forelimb Akinesia in Parkinsonian Rats

E. Kip, L. Bentall, C. F. Underwood, S. M. Hughes, L. C. Parr-Brownlie

Summary: Parkinson's disease is a motor disorder caused by altered neural activity, and optogenetic stimulation of glutamatergic motor thalamus neurons has shown potential in alleviating limb immobility in a rat model of Parkinson's disease, suggesting it as an alternative treatment for Parkinson's disease.

NEUROSCIENCE (2022)

Article Clinical Neurology

Acquired Stuttering in Parkinson's Disease

Eloise A. Gooch, Kyla-Louise Horne, Tracy R. R. Melzer, Megan J. J. McAuliffe, Michael MacAskill, John C. C. Dalrymple-Alford, Tim J. J. Anderson, Catherine Theys

Summary: New-onset stuttering occurs in individuals with Parkinson's disease and is related to cognitive and motor functioning. People with Parkinson's disease have a higher occurrence of stuttering during conversation compared to controls. The frequency of stuttering is associated with disease onset, medication dosage, and cognitive and motor scores.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

暂无数据